{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:09Z","timestamp":1790423229529,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.semnephrol.2013.04.007","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T22:55:15Z","timestamp":1376434515000},"page":"265-276","source":"Crossref","is-referenced-by-count":21,"title":["Endocrine and Hypertensive Disorders of Potassium Regulation: Primary Aldosteronism"],"prefix":"10.1016","volume":"33","author":[{"given":"I. David","family":"Weiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2013.04.007_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74868-6","article-title":"Potentially high prevalence of primary aldosteronism in a primary-care population","volume":"353","author":"Lim","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib2","first-page":"39","article-title":"Laboratory investigation of primary aldosteronism","volume":"31","author":"Stowasser","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","article-title":"Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio","volume":"37","author":"Gallay","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib7","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/HCO.0b013e32834a6fe8","article-title":"Atherosclerotic renal artery stenosis: update on management strategies","volume":"26","author":"Meier","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib10","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/eurheartj\/ehq510","article-title":"Renovascular hypertension: screening and modern management","volume":"32","author":"Baumgartner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MNH.0b013e328342bb35","article-title":"Issues in renovascular disease and ischemic nephropathy: beyond ASTRAL","volume":"20","author":"Textor","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib12","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1152\/ajprenal.00257.2005","article-title":"Kidney function in mice lacking aldosterone","volume":"290","author":"Makhanova","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000088321.67254.B7","article-title":"Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: role of pendrin in mineralocorticoid-induced hypertension","volume":"42","author":"Verlander","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib14","doi-asserted-by":"crossref","first-page":"14552","DOI":"10.1073\/pnas.95.24.14552","article-title":"The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein","volume":"95","author":"Kim","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib15","doi-asserted-by":"crossref","first-page":"C1373","DOI":"10.1152\/ajpcell.1998.274.5.C1373","article-title":"Hormonal regulation of ENaCs: insulin and aldosterone","volume":"274","author":"Blazer-Yost","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib16","doi-asserted-by":"crossref","first-page":"13368","DOI":"10.1073\/pnas.1202671109","article-title":"Double knockout of pendrin and Na-Cl cotransporter (NCC) causes severe salt wasting, volume depletion, and renal failure","volume":"109","author":"Soleimani","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ndt\/gfl702","article-title":"Primary hyperaldosteronism in a patient with end stage renal disease","volume":"22","author":"Kazory","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib18","first-page":"R526","article-title":"Effects of aldosterone on potassium distribution","volume":"243","author":"Young","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib19","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2000.00970.x","article-title":"Aldosterone and potassium secretion by the cortical collecting duct","volume":"57","author":"Palmer","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib20","first-page":"365","article-title":"Aldosterone regulation of sodium and potassium transport in the cortical collecting duct","volume":"10","author":"O'Neil","year":"1990","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.HYP.4.2.279","article-title":"Experimental aldosterone hypertension in the dog","volume":"4","author":"Pan","year":"1982","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib22","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/ki.1996.258","article-title":"Aldosterone and potassium homeostasis","volume":"49","author":"Rabinowitz","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib23","first-page":"R526","article-title":"Effects of aldosterone on potassium distribution","volume":"243","author":"Young","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib24","first-page":"F239","article-title":"Differential regulation of ROMK expression in kidney cortex and medulla by aldosterone and potassium","volume":"275","author":"Wald","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1469-7793.1998.629bm.x","article-title":"Regulation of distal nephron K+ channels (ROMK) mRNA expression by aldosterone in rat kidney","volume":"509","author":"Beesley","year":"1998","journal-title":"J Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1681\/ASN.2010030311","article-title":"Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases","volume":"22","author":"Greenlee","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib27","first-page":"F257","article-title":"Extrarenal potassium homeostasis","volume":"240","author":"Bia","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib28","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1046\/j.1523-1755.2001.0590051850.x","article-title":"Chronic potassium depletion induces renal injury, salt sensitivity, and hypertension in young rats","volume":"59","author":"Ray","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib29","doi-asserted-by":"crossref","first-page":"F620","DOI":"10.1152\/ajprenal.2001.281.4.F620","article-title":"Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity","volume":"281","author":"Suga","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00000441-199707000-00008","article-title":"The effects of potassium depletion and supplementation on blood pressure: a clinical review","volume":"314","author":"Barri","year":"1997","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib31","first-page":"145","article-title":"Vascular resistance and reactivity in hypertensive rats","volume":"11","author":"Finch","year":"1974","journal-title":"Blood Vessels"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.RES.46.5.619","article-title":"Changes in renal vascular reactivity at various stages of deoxycorticosterone hypertension in rats","volume":"46","author":"Berecek","year":"1980","journal-title":"Circ Res"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib33","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.HYP.21.6.929","article-title":"Vasodilation to acetylcholine in primary and secondary forms of human hypertension","volume":"21","author":"Taddei","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib35","doi-asserted-by":"crossref","first-page":"F664","DOI":"10.1152\/ajprenal.00353.2002","article-title":"Early transcriptional effects of aldosterone in a mouse inner medullary collecting duct cell line","volume":"285","author":"Gumz","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib36","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/en.2003-0109","article-title":"Regulation of aldosterone synthase gene expression in the rat adrenal gland and central nervous system by sodium and angiotensin II","volume":"144","author":"Ye","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.tem.2003.10.004","article-title":"Is aldosterone synthesized in the CNS regulated and functional?","volume":"14","author":"Gomez-Sanchez","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00711577","article-title":"Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system","volume":"13","author":"Herman","year":"1993","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib39","doi-asserted-by":"crossref","first-page":"R994","DOI":"10.1152\/ajpregu.90903.2008","article-title":"Leenen FHH. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats","volume":"296","author":"Huang","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/01.HYP.11.6.750","article-title":"Hypertensive mechanisms associated with centrally administered aldosterone in dogs","volume":"11","author":"Kageyama","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib41","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1152\/ajpendo.1992.262.1.E96","article-title":"Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S\/JR rats","volume":"262","author":"Gomez-Sanchez","year":"1992","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib42","doi-asserted-by":"crossref","first-page":"E482","DOI":"10.1152\/ajpendo.1990.258.3.E482","article-title":"Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib43","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1210\/jc.2010-0823","article-title":"Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism","volume":"95","author":"Kontak","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib44","doi-asserted-by":"crossref","first-page":"H517","DOI":"10.1152\/ajpheart.00651.2004","article-title":"Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats","volume":"288","author":"Huang","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib45","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.steroids.2011.12.023","article-title":"Nongenomic actions of aldosterone and progesterone revisited","volume":"77","author":"Wendler","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","article-title":"GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone","volume":"57","author":"Gros","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0039-128X(99)00087-2","article-title":"Mineralocorticoid action","volume":"65","author":"Rogerson","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00041552-200103000-00011","article-title":"Non-genomic actions of aldosterone: role in hypertension","volume":"10","author":"Funder","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1210\/er.2005-0004","article-title":"The nongenomic actions of aldosterone","volume":"26","author":"Funder","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib52","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.ph.50.030188.002205","article-title":"Regulation of aldosterone secretion","volume":"50","author":"Quinn","year":"1988","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib55","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM198511213132106","article-title":"Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis","volume":"313","author":"Laragh","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib56","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1530\/acta.0.0800095","article-title":"Diurnal variations of plasma aldosterone in supine man: relationship to plasma renin activity and plasma cortisol","volume":"80","author":"Armbruster","year":"1975","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1981.tb00190.x","article-title":"Studies of diurnal changes in plasma renin activity, and plasma noradrenaline, aldosterone and cortisol concentrations in man","volume":"14","author":"Lightman","year":"1981","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib58","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1172\/JCI105310","article-title":"The biosynthesis of adrenal steroids: effects of angiotensin II, adrenocorticotropin, and potassium","volume":"44","author":"Kaplan","year":"1965","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib59","first-page":"24S","article-title":"Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system: endogenous antagonists","volume":"87","author":"Johnston","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib60","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1152\/ajpendo.1992.263.2.E181","article-title":"Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s)","volume":"263","author":"Ganguly","year":"1992","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ki.1979.37","article-title":"Effect of potassium chloride on plasma renin activity and plasma aldosterone during sodium restriction in normal man","volume":"15","author":"Bauer","year":"1979","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib62","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib63","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.111.186205","article-title":"Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?","volume":"59","author":"Gomez-Sanchez","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypert"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib65","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI28764","article-title":"Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice","volume":"117","author":"Billet","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib66","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism - The Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib67","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","article-title":"Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication","volume":"150","author":"Seiler","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib68","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism--careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib70","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","article-title":"Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism","volume":"40","author":"Mulatero","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib73","unstructured":"Weiner ID, Wingo CS. Endocrine causes of hypertension: aldosterone. In: Johnson RJ, Fluege J, Feehally J, editors. Comprehensive clinical nephrology. St Louis: Elsevier, 2010.p.469-76."},{"key":"10.1016\/j.semnephrol.2013.04.007_bib74","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","article-title":"Captopril test can give misleading results in patients with suspect primary aldosteronism","volume":"50","author":"Mulatero","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib75","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension","volume":"55","author":"de Souza","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib77","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/HJH.0b013e3283455ca5","article-title":"A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism","volume":"29","author":"Parthasarathy","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib78","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.amjhyper.2005.06.010","article-title":"Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?","volume":"18","author":"Mahmud","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib79","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib80","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.86.3.1066","article-title":"Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism","volume":"86","author":"Magill","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib81","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","article-title":"Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes","volume":"93","author":"Mulatero","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib82","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib83","first-page":"1","volume":"19","year":"2002","journal-title":"NIH Consens State Sci Statements"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib84","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn's Registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib85","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/HJH.0b013e3282f9e66a","article-title":"Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib86","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0b013e3181961d77","article-title":"Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism","volume":"249","author":"Auchus","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib87","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.111.189548","article-title":"Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism","volume":"59","author":"Monticone","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib88","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jc.86.3.1083","article-title":"Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases","volume":"86","author":"Rossi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","article-title":"Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism","volume":"53","author":"Seccia","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib90","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/eje.1.02164","article-title":"Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites","volume":"154","author":"Schirpenbach","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1365-2362.2000.0300s3083.x","article-title":"Metabolism of glucocorticoids and mineralocorticoids in patients with adrenal incidentalomas","volume":"30","author":"Maser-Gluth","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib92","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/145749690809700308","article-title":"The role of adrenal scintigraphy in the preoperative management of primary aldosteronism","volume":"97","author":"Volpe","year":"2008","journal-title":"Scand J Surg"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib93","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","article-title":"131I-6b-Iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results","volume":"50","author":"Yen","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10741-005-2345-1","article-title":"Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis","volume":"10","author":"Sica","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib95","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A Comparison of the aldosterone-blocking agents eplerenone and spironolactone","volume":"31","author":"Struthers","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib96","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1038\/npp.2011.162","article-title":"A randomized trial on mineralocorticoid receptor blockade in men: effects on stress responses, selective attention, and memory","volume":"36","author":"Cornelisse","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib97","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ahj.2004.10.005","article-title":"Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure","volume":"148","author":"Tamirisa","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2013.04.007_bib98","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929513000569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929513000569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T19:06:42Z","timestamp":1563649602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929513000569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0270929513000569"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2013.04.007","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}